Activity: Other activity types › Hosting a delegation or group
Description
Invited participant to advise and run the clinical development of CXCR2 inhibitors in castrate-resistant prostate cancer through academic consortia with Prof Johann de Bono (Royal Marsden Hospital) and Prof Alessandro Alimonti (Lugano, Switzerland). Teleconferences will agree trial protocol, external funding, patient recruitment etc.